Bayer — Drug Prices & Medicare Spending
Bayer manufactures 8 drugs tracked by Medicare Part D with total spending of $3.0B.
8
Drugs Tracked
$3.0B
Medicare Spending
$241.96
Avg Cost/Claim
100%
Have Generics
Bayer Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Nubeqa | Darolutamide | $7,910.00 | Yes |
| 2 | Adempas | Riociguat | $9,500.00 | Yes |
| 3 | Stivarga | Regorafenib | $12,321.00 | Yes |
| 4 | Kerendia | Finerenone | $399.00 | Yes |
| 5 | Nexavar | Sorafenib | $8,357.00 | Yes |
| 6 | Betaseron | Interferon Beta-1b | $5,571.00 | Yes |
| 7 | Ciprofloxacin | Ciprofloxacin | $14.00 | Yes |
| 8 | Nifedipine | Nifedipine ER | $18.00 | Yes |
Frequently Asked Questions
Bayer manufactures 8 drugs tracked by Medicare Part D, with total annual spending of $3.0B.
Stivarga (Regorafenib) is the most expensive at $12,321.00 per claim.
8 of 8 Bayer drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.